Schizophrenia drug will require patients to be re-enrolled, prescribers re-certified The FDA announced an update to the Risk Evaluation and Mitigation Strategy (REMS) for the schizophrenia drug clozapine.The changes, which will...
Findings may explain multiple eye disorders linked to Covid-19 Evidence of SARS-CoV-2 virus in the retinas of three people who died of Covid-19 may help explain the host of ophthalmic disorders associated with the disease.On...
Company officials announce plans to seek approval for booster dose Data published Wednesday ahead of peer review show the Pfizer-BioNTech Covid-19 vaccine, BNT162b2, continues to provide almost universal protection against...
EUA covers hospitalized patients on respiratory support The FDA revised its Emergency Use Authorization (EUA) for baricitinib (Olumiant) to treat Covid-19 in hospitalized patients age 2 years and older who are receiving...
